Acetaminophen Reagents Market Size & Growth | Report by 2028

The acetaminophen reagents market is projected to reach US$ 750.39 million by 2028 from US$ 539.56 million in 2021; it is expected to grow at a CAGR of 4.8% from 2021 to 2028.

Acetaminophen (paracetamol) is the commonly used analgesic and antipyretic across the world. Acetaminophen reagents are drug testing reagents used to determine the presence of an excessive amount of acetaminophen in a blood sample. The reagents are also used to assess drug levels and are an essential metric in the treatment and dose management of patients suffering from severe renal failure. Factors such as the high incidence of a drugs overdose and the adoption of acetaminophen testing drive the market growth. However, the increased risk of attention deficit hyperactivity disorder (ADHD) and other complications in pregnancy restrict the growth of the market. Further, during the forecast period, the presence of limited key players in the market is expected to offer significant growth opportunities to the market players to expand their customer base, especially in developing countries.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Acetaminophen Reagents Market: Strategic Insights

Market Size Value in	US$ 539.56 million in 2021
Market Size Value by	US$ 750.39 million by 2028
Growth rate	CAGR of 4.8% from 2021 to 2028
Forecast Period	2021-2028
Base Year	2021

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

The global impacts of COVID-19 outbreak are being felt across several markets. Although the healthcare sector witnessed outbreaks of many viruses, such as SARS and H1N1, in the last few years, the severity of the SARS-CoV-2 made the situation complicated due to its mode of transmission. North America is one of the most important regions for adopting and growing new technologies due to flattering government policies to boost innovation, a vast industrial base, and high purchasing power, mainly in developed countries such as the US and Canada. Hence, any impact on the industries operations’ affects the region's economic growth. North America witnessed growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, as of December 1st, 2021, the number of cases reached 61,124,468 with 1,218,505 deaths, while 823,390 deaths were reported in the US alone. A similar impact was noticed in Mexico and Canada. As a result, healthcare systems were overburdened, and the delivery of medical care to all patients became a challenge in the region, and the sudden surge in the number of infections led to a shortage of emergency health supplies. To manage the outbreak, the government took preventive measures, such as countrywide lockdowns and social distancing policies. In addition, the pharmaceuticals and medical device industry faced the negative impact of the pandemic. As the COVID-19 pandemic continues to unfold, the companies faced difficulties in managing their operations. Many acetaminophen reagents companies in the US were severely impacted due to disrupted and restricted company’s ability to distribute products and temporary closures of facilities. Moreover, market players witnessed disruption in their business operations. Also, slumped demand for products had a marginal negative impact on the North America acetaminophen reagents market

Lucrative Regions for Acetaminophen reagents Market

Market Insights

High Incidence of Drugs Overdose Fuels Acetaminophen Reagents Market Growth

Acetaminophen is a commonly used oral antipyretic and analgesic with an excellent safety profile when administered in proper therapeutic doses. It is an over-the-counter (OTC) medicine and is widely available. Acetaminophen can be found in numerous products, due to which people underestimate its toxicity. Various OTC cold and flu medicines contain acetaminophen. The generalized dosage of acetaminophen in adults is up to 3,000 mg of single-ingredient acetaminophen a day and less than 3,000 mg for patients aged 65 years and above. Patients ingest excessive amounts of medicine as they misunderstand dosing directions or cannot recognize the availability of acetaminophen in more than one medication they are using. Consumption of more than decided amounts, especially 7,000 mg or more, can lead to severe overdose problems such as, acute hepatic failure, or become deadly. If a person consumes more than one of OTC medicines containing acetaminophen in the same period, a dangerously high amount of acetaminophen can be found in the blood that can damage the liver. If a patient has any liver or kidney disease history, then the usage of this drug first needs to be discussed with the healthcare provider.

Acetaminophen overdose is one of the major causes of overdose-related acute hepatic failure and death. If the liver damage is severe, its transplant may be required to save the patient’s life. After developing liver failure, every third of patients require liver transplantation. According to a “Massive Acetaminophen Overdose” report, acetaminophen toxicity accounts for nearly half of all liver transplantations in the US. Each year, in the US, acetaminophen-associated overdoses lead to 56,000 emergency room visits and 26,000 hospitalizations. The analysis of national mortality files showed that each year 458 deaths occur due to the same reason, of which 100 deaths are almost unintentional. In Canada, nearly 4,500 hospitalizations are recorded yearly due to acetaminophen overdose, of which 700 cases of overdose are unintentional. Therefore, as the incidence of acetaminophen overdose increases along with rising hospitalizations and emergency room visits, the need to reduce the strength of the acetaminophen medications and dose management in patients rises, which propels the demand for accurate testing to determine level of drug. Increasing accurate acetaminophen testing favors the growth of the acetaminophen reagents market.

Product-Based Insights

The global acetaminophen reagents market, based on product, is segmented into antibody/substrate reagent, enzyme reagent, acetaminophen antiserum, acetaminophen fluorescein tracer, and pretreatment solution. In 2021, the antibody/substrate reagent segment held the largest share of the market.Antibody/substrate reagent is a primary chemical reagent used to carry out the acetaminophen test. The reagents are offered by various companies in the global acetaminophen reagents market. For instance, Beckman Coulter, Inc. offers antibody/substrate reagent (OSR7A568 R1) in its Emit tox Acetaminophen Assay used for the quantitative analysis of acetaminophen in human serum or plasma.

Acetaminophen Reagents Market, by Product – 2021 and 2028

Access Data

Application-Based Insights

The acetaminophen reagents market, based on application, is bifurcated into enzymatic assays and immunoassay. In 2021, the enzymatic assays segment held a larger share of the market. Moreover, the immunoassay segment is expected to register a higher CAGR during 2021 to 2028.

End Users-Based Insights

The acetaminophen reagents market, based on end users, is segmented into hospitals, diagnostics laboratories, POC testing, forensic laboratories, and others. The hospitals segment held the largest share of the market in 2021. Also, the diagnostics laboratories segment is anticipated to register the highest CAGR in the market during the forecast period.

Companies operating in the acetaminophen reagents market adopt the treatment innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

The report segments acetaminophen reagents market as Follows:

Based on product, the acetaminophen reagents market is segmented into antibody/substrate reagent, enzyme reagent, acetaminophen antiserum, acetaminophen fluorescein tracer, and pretreatment solution. Based on application, the market is bifurcated into Enzymatic Assays and Immunoassay. Based on end users, the market is segmented into hospitals, diagnostics laboratories, POC testing, forensic laboratories, and others.  By geography, the global acetaminophen reagents market is segmented into North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. The market in North America is further segmented into the US, Canada, and Mexico. The Europe acetaminophen reagents market is sub-segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The acetaminophen reagents market in the Asia Pacific is further sub-segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. The market in South and Central America is sub-segmented into Brazil, Argentina, and the Rest of South and Central America. The Middle East and Africa acetaminophen reagents market is further sub-segmented into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East and Africa.

Company Profiles

Biorbyt Ltd., Thermo Fisher Scientific Inc., Siemens Healthineers AG, Abbott, Sekisui Diagnostics, Beckman Coulter, Inc., Randox Laboratories, Ltd., American Screening Corporation, Inc., EKF Diagnostics, Bio-Rad Laboratories Inc. are among the leading companies operating in the market.